2019
DOI: 10.1111/jocd.13105
|View full text |Cite
|
Sign up to set email alerts
|

Advances in encapsulated dermal formulations in chemoprevention of melanoma: An overview

Abstract: Background The three forms of skin cancer are cutaneous malignant melanoma, basal cell carcinoma, and squamous cell carcinoma. Melanoma skin cancer is an aggressive type and one of the most chemotherapy‐resistant malignancies. Conventional topical products are beset with limitations, leading to lower efficacy. There is a growing need to develop topical formulations encapsulated in polymeric and lipid nanoparticles, nanoemulsions, dendrimers, and liposomes exhibiting enhanced skin penetration and longer skin re… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
6
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(6 citation statements)
references
References 41 publications
(59 reference statements)
0
6
0
Order By: Relevance
“…Transfersomes have the same advantages of liposomes, thanks to the inner aqueous compartment surrounded by lipid bilayers and the biocompatibility of the components. Moreover, their development improved the efficiency of vesicular systems in topical application [ 48 ]. The elastic behavior of transfersomes given by the presence of ellagic acid improves their penetration through the skin, allowing the transdermal delivery of encapsulated drugs, when in non-occlusive conditions [ 38 , 49 ].…”
Section: Lipid-based Nanosystemsmentioning
confidence: 99%
See 2 more Smart Citations
“…Transfersomes have the same advantages of liposomes, thanks to the inner aqueous compartment surrounded by lipid bilayers and the biocompatibility of the components. Moreover, their development improved the efficiency of vesicular systems in topical application [ 48 ]. The elastic behavior of transfersomes given by the presence of ellagic acid improves their penetration through the skin, allowing the transdermal delivery of encapsulated drugs, when in non-occlusive conditions [ 38 , 49 ].…”
Section: Lipid-based Nanosystemsmentioning
confidence: 99%
“…The employment of non-ionic surfactants mainly benefits both topical and transdermal delivery since they are considered nontoxic and non-irritant as compared to both cationic and anionic surfactants [ 62 , 63 ]. The amphiphilic nature of the system ensures the main advantages reported for liposomes, such as the encapsulation of both hydrophilic and hydrophobic drugs as well as their biodegradability [ 33 , 48 , 59 ]. However, the presence of non-ionic surfactants instead of lipids guarantees the physical and chemical stability of the system and easy formulation with low-cost and large-scale production [ 59 , 64 ].…”
Section: Lipid-based Nanosystemsmentioning
confidence: 99%
See 1 more Smart Citation
“…In the area of skin cancer prevention, nanotechnology-based drug formulation such as nanoemulsion of 5-fluorouracil, bromelain polymeric NPs using PLGA, solid lipid NPs of doxorubicin, 5-flurouracil have been reported (Bhatnagar et al, 2015;Shakeel et al, 2015;Ravikumar and Tatke, 2019). Use of NPs to enhance the skin deposition of chemopreventive agents is an ideal way to enhance the chemopreventive efficacy.…”
Section: Miscellaneous Cancersmentioning
confidence: 99%
“…Such examples include shell-enriched solid lipid NPs of 5-fluorouracil, curcumin-ceramide niososmes, etc. (Heenatigala Palliyage et al, 2019;Ravikumar and Tatke, 2019). NPs have also been developed and studied to elicit enhanced protection against UV radiation.…”
Section: Miscellaneous Cancersmentioning
confidence: 99%